BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25551557)

  • 1. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.
    Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ
    PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.
    Pasic I; Shlien A; Durbin AD; Stavropoulos DJ; Baskin B; Ray PN; Novokmet A; Malkin D
    Cancer Res; 2010 Jan; 70(1):160-71. PubMed ID: 20048075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
    Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
    Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma.
    Kresse SH; Rydbeck H; Skårn M; Namløs HM; Barragan-Polania AH; Cleton-Jansen AM; Serra M; Liestøl K; Hogendoorn PC; Hovig E; Myklebost O; Meza-Zepeda LA
    PLoS One; 2012; 7(11):e48262. PubMed ID: 23144859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.
    Both J; Wu T; Bras J; Schaap GR; Baas F; Hulsebos TJ
    PLoS One; 2012; 7(1):e30907. PubMed ID: 22292074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of gene expression and genomic aberration data in osteosarcoma (OS).
    Xiong Y; Wu S; Du Q; Wang A; Wang Z
    Cancer Gene Ther; 2015 Nov; 22(11):524-9. PubMed ID: 26427513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcoma.
    Maire G; Martin JW; Yoshimoto M; Chilton-MacNeill S; Zielenska M; Squire JA
    Cancer Genet; 2011 Mar; 204(3):138-46. PubMed ID: 21504713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single nucleotide polymorphism microarray analysis in cortisol-secreting adrenocortical adenomas identifies new candidate genes and pathways.
    Ronchi CL; Leich E; Sbiera S; Weismann D; Rosenwald A; Allolio B; Fassnacht M
    Neoplasia; 2012 Mar; 14(3):206-18. PubMed ID: 22496620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data.
    Kuijjer ML; Rydbeck H; Kresse SH; Buddingh EP; Lid AB; Roelofs H; Bürger H; Myklebost O; Hogendoorn PC; Meza-Zepeda LA; Cleton-Jansen AM
    Genes Chromosomes Cancer; 2012 Jul; 51(7):696-706. PubMed ID: 22454324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
    Du X; Yang J; Yang D; Tian W; Zhu Z
    BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number analysis identifies tumor suppressive lncRNAs in human osteosarcoma.
    Xie J; Lin D; Lee DH; Akunowicz J; Hansen M; Miller C; Sanada M; Kato M; Akagi T; Kawamata N; Ogawa S; Koeffler HP
    Int J Oncol; 2017 Mar; 50(3):863-872. PubMed ID: 28197627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.
    Yang J; Zhao L; Tian W; Liao Z; Zheng H; Wang G; Chen K
    BMC Med Genomics; 2013 Dec; 6():56. PubMed ID: 24330824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent chromosome 22 deletions in osteoblastoma affect inhibitors of the Wnt/beta-catenin signaling pathway.
    Nord KH; Nilsson J; Arbajian E; Vult von Steyern F; Brosjö O; Cleton-Jansen AM; Szuhai K; Hogendoorn PC
    PLoS One; 2013; 8(11):e80725. PubMed ID: 24236197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of the tumor suppressor CMTM8 and its association with prognosis in bladder cancer.
    Zhang S; Pei X; Hu H; Zhang W; Mo X; Song Q; Zhang Y; Xu K; Wang Y; Na Y
    Tumour Biol; 2016 May; 37(5):6217-25. PubMed ID: 26615421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic heterogeneity of osteosarcoma - shift from single candidates to functional modules.
    Poos K; Smida J; Maugg D; Eckstein G; Baumhoer D; Nathrath M; Korsching E
    PLoS One; 2015; 10(4):e0123082. PubMed ID: 25848766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
    Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China.
    Zhang Y; Xue Q; Pan G; Meng QH; Tuo X; Cai X; Chen Z; Li Y; Huang T; Duan X; Duan Y
    PLoS One; 2017; 12(1):e0169098. PubMed ID: 28056099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.